BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Lupus Nephritis
Interventions
BIOLOGICAL

BIIB023

DRUG

mycophenolate mofetil

titrated to a target daily dose of 2 g (1 g twice daily)

DRUG

oral corticosteroids

oral corticosteroids (prednisone or equivalent) at a target prednisone dose of 10 mg/day

Trial Locations (33)

1008

Research Site, Manila

1102

Research Site, Quezon City

3000

Research Site, Leuven

3052

Research Site, Melbourne

4000

Research Site, Liège

4032

Research Site, Debrecen

10330

Research Site, Pathumwan

10700

Research Site, Bangkoknoi

11020

Research Site, Lake Success

33604

Research Site, Pessac

38119

Research Site, Memphis

41200

Research Site, Kuala Selangor

43000

Research Site, Kuala Selangor

43210

Research Site, Columbus

46520

Research Site, Sagunto

56126

Research Site, Pisa

59100

Research Site, Kuala Lumpur

75651

Research Site, Paris

79905

Research Site, El Paso

93586

Research Site, Kuching

123182

Research Site, Moscow

Unknown

Research Site, Ciudad Autonoma Buenos Aires

Research Site, San Juan

Research Site, San Miguel de Tucumán

Research Site, Barranquilla

Research Site, Bogotá

Research Site, Medellín

Research Site, Shatin

Research Site, Lima

78040-360

Research Site, Cuiabá

06090

Research Site, Cuauhtémoc

90-153

Research Site, Lodz

443-380

Research Site, Suwon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY